• Users Online: 1067
  • Print this page
  • Email this page
Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Citation statistics : Table of Contents
   2018| September-October  | Volume 1 | Issue 5  
    Online since October 25, 2018

 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Show all abstracts  Show selected abstracts  Export selected to
  Cited Viewed PDF
ORIGINAL ARTICLES
BRAF mutation marks out specific subgroups of glioma
Aden Ka-Yin Chan, Riki Rui-Qi Zhang, Abudumijiti Aibaidula, Zhi Feng Shi, Hong Chen, Ying Mao, Ho Keung Ng
September-October 2018, 1(5):168-174
DOI:10.4103/glioma.glioma_33_18  
  5 5,161 548
Quinacrine enhances temozolomide cytotoxicity in temozolomide-sensitive and -resistant glioblastoma cells
Pingde Zhang, Ning Li, Karrie Mei Yee Kiang, Zhiyuan Zhu, Gloria Wai Man Leung, Stephen Yin Cheng, Gilberto Ka Kit Leung
September-October 2018, 1(5):175-181
DOI:10.4103/glioma.glioma_37_18  
  4 3,760 373
REVIEWS
How does one do next-generation sequencing for brain tumors in the clinical laboratories?
Kay Ka-Wai Li, Ho-Keung Ng
September-October 2018, 1(5):149-154
DOI:10.4103/glioma.glioma_36_18  
  1 5,232 536
Precision cancer therapeutics for glioma
Danny Tat Ming Chan
September-October 2018, 1(5):155-158
DOI:10.4103/glioma.glioma_34_18  
  1 3,007 377
Advances in exosome-related biomarkers for glioblastoma: Basic research and clinical application
Yuzhen Jiang, Jiaying Qian, Jun Yang, Xiaoling Yan, Xiaoying Xue, Qing Chang
September-October 2018, 1(5):159-167
DOI:10.4103/glioma.glioma_35_18  
  1 4,049 514
EDITORIAL
The times they are a-changin' – How molecular pathology will change practice
Ho-Keung Ng
September-October 2018, 1(5):147-148
DOI:10.4103/glioma.glioma_32_18  
  - 2,800 405